GELESIS
Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Gelesis was founded in 2006 in Boston, Massachusetts
GELESIS
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2006-02-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.gelesis.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
312.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome
Similar Organizations
BIOMODEX
BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.
EicOsis
EicOsis Human Health is developing a first-in-class therapy of a once daily
iCAD
iCAD develops and delivers cancer detection and radiation therapy solutions, and services that enable clinicians to find and treat cancers.
Retina Implant
Retina Implant is a biotech company which develops subretinal implants for partially sighted and blind patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kennedy Lewis Investment Management
Kennedy Lewis Investment Management investment in Post-IPO Equity - Gelesis
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Post-IPO Equity - Gelesis
China Medical System Holdings Limited
China Medical System Holdings Limited investment in Post-IPO Equity - Gelesis
Daphne Zohar
Daphne Zohar investment in Post-IPO Equity - Gelesis
Pimco
Pimco investment in Post-IPO Equity - Gelesis
Hambro Perks Ltd.
Hambro Perks Ltd. investment in Secondary Market - Gelesis
Vitruvian Partners
Vitruvian Partners investment in Private Equity Round - Gelesis
Cormorant Asset Management
Cormorant Asset Management investment in Private Equity Round - Gelesis
PureTech Health
PureTech Health investment in Private Equity Round - Gelesis
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Private Equity Round - Gelesis
Official Site Inspections
http://www.gelesis.com Semrush global rank: 1.38 M Semrush visits lastest month: 20.81 K
- Host name: cluster027.hosting.ovh.net
- IP address: 54.36.91.62
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
